MedTrace Logo

Clinical Evaluation of Two Monthly Contact Lenses

NCT03459131 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-03-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to explore overall vision with BIOFINITY® ENERGYS™ contact lenses as compared to BIOFINITY® contact lenses after one week of wear.

Conditions

  • Refractive Errors

Interventions

DEVICE

Comfilcon A with Digital Zone Optics™ contact lenses

Silicone hydrogel spherical contact lenses with Digital Zone Optics™

DEVICE

Comfilcon A contact lenses

Silicone hydrogel spherical contact lenses

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Alcon, A Novartis Division · Alcon, A Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-07
Primary Completion
2018-03-26
Completion
2018-03-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03459131 on ClinicalTrials.gov